First Trust Advisors LP Catalyst Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

$108 Billion
Q1 2025

A detailed history of First Trust Advisors LP transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 242,166 shares of CPRX stock, worth $6.14 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

242,166

Previous 2,233,834 89.16%

Holding current value

$6.14 Million

Previous $46.6 Million 87.4%

% of portfolio

0.01%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$19.53 - $25.74 $38.9 Million - $51.3 Million	-1,991,668 Reduced 89.16%	242,166 $5.87 Million
Q4 2024 Feb 13, 2025	SELL	$19.73 - $23.93 $3.85 Million - $4.67 Million	-195,139 Reduced 8.03%	2,233,834 $46.6 Million
Q3 2024 Nov 13, 2024	SELL	$15.19 - $21.35 $667,752 - $938,546	-43,960 Reduced 1.78%	2,428,973 $48.3 Million
Q2 2024 Aug 13, 2024	BUY	$14.68 - $16.92 $33 Million - $38.1 Million	2,248,850 Added 1003.58%	2,472,933 $38.3 Million
Q1 2024 May 13, 2024	BUY	$13.18 - $17.11 $1.64 Million - $2.13 Million	124,238 Added 124.43%	224,083 $3.57 Million
Q4 2023 Feb 13, 2024	BUY	$11.78 - $17.29 $64,507 - $94,680	5,476 Added 5.8%	99,845 $1.68 Million
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $817,996 - $1.05 Million	-69,974 Reduced 42.58%	94,369 $1.1 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $1.89 Million - $2.97 Million	164,343 New	164,343 $2.21 Million
Q4 2022 Feb 09, 2023	BUY	$12.25 - $19.5 $2.05 Million - $3.26 Million	167,435 New	167,435 $3.11 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $27,424 - $37,725	-4,402 Reduced 2.99%	142,629 $1 Million
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $45,320 - $70,925	-8,535 Reduced 5.49%	147,031 $1.22 Million
Q4 2021 Feb 08, 2022	BUY	$5.21 - $7.45 $101,115 - $144,589	19,408 Added 14.25%	155,566 $1.05 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $523,334 - $651,740	-107,904 Reduced 44.21%	136,158 $722,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $40,759 - $57,481	-9,501 Reduced 3.75%	244,062 $1.4 Million
Q1 2021 May 14, 2021	BUY	$3.45 - $4.69 $70,217 - $95,455	20,353 Added 8.73%	253,563 $1.17 Million
Q4 2020 Feb 02, 2021	SELL	$2.97 - $3.83 $30,014 - $38,705	-10,106 Reduced 4.15%	233,210 $779,000
Q3 2020 Nov 05, 2020	BUY	$2.97 - $5.08 $722,648 - $1.24 Million	243,316 New	243,316 $723,000

Others Institutions Holding CPRX

# of Institutions

389

Shares Held

99.3M

Call Options Held

37K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.61B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Catalyst Pharmaceuticals, Inc. Transaction History